Dr. Sara E Crann, PhD
Claim this profileStudies Sexual Assault
1 reported clinical trial
2 drugs studied
More about Sara E Crann, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Sara E Crann, PhD has experience with
- A-EAAA Sexual Assault Resistance Education Program
- Usual Care + A-EAAA At 6 Months
Breakdown of trials Sara E Crann, PhD has run
Sexual Assault
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sara E Crann, PhD specialize in?
Sara E Crann, PhD focuses on Sexual Assault and other conditions. In particular, much of their work with Sexual Assault has involved treating patients, or patients who are undergoing treatment.
Is Sara E Crann, PhD currently recruiting for clinical trials?
No, Sara E Crann, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Sara E Crann, PhD has studied deeply?
Yes, Sara E Crann, PhD has studied treatments such as A-EAAA Sexual Assault Resistance Education Program, Usual care + A-EAAA at 6 months.
What is the best way to schedule an appointment with Sara E Crann, PhD?
Apply for one of the trials that Sara E Crann, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.